A lot of #biotech companies are currently in a hiring freeze for full time employees (FTE)... If you are a team/project leader, this is challenging because you still have deadlines to meet. This is even more critical when those deadlines directly tie to your company's next round of funding (aka your job security). I have recently helped several clients identify consultants (SME's) for unique needs to help them bridge the gap in critical projects until they receive approval for the next round of full time hires or funding. Here are some of the skills sets that are in my network. All of the consultants I work with are veterans in their field and can come in and hit the ground running. Most of these folks have experience in biologics and/or cell therapy. A few in small molecule. ▶ Regulatory Affairs CMC ▶ Supply Chain and External Manufacturing ▶ Process Development, Analytical Sciences, Formulation ▶ Quality Assurance/Quality Systems ▶ CMC Project Management ▶ Clinical Quality Assurance (CQA) ▶ Clinical Ops Message me if you have a time-critical project and need an industry expert that can quickly push things forward. #sme #consultants #cmc #qualityassurance #celltherapy #TCR #cart #biologics #mAbs #antibody Nexagen Search
Jeff Caskey’s Post
More Relevant Posts
-
Here are some of the companies that announced funding last week in the biotech industry 🔽 Brenus Pharma | Series A | £14M | 🇫🇷 Clinical-stage biotech developing a technology platform, Stimulated-Tumor-Cell (STC) designed to generate 'first-in-class', 'off-the-shelf' therapeutic cancer vaccine Nura Bio | Series A | $68M | 🇺🇸 Private biotechnology company developing small molecule drugs for neurodegenerative conditions GC Therapeutics | Series A | $65M | 🇺🇸 Biopharmaceutical company created to scale and unlock the next generation of cell therapy-based medicines utilizing its' iPSC programming platform, TFome™ PictorLabs Inc | Series B | $30M | 🇺🇸 Software company that is transforming the practice of histopathology with AI-powered virtual staining Nomic Bio | Series B | $42M | 🇨🇦 Bioengineering company working to make the human proteome as broadly and easily accessible as the human genome Arzeda | Series C | $38M | 🇺🇸 Synthetic biology company that creates novel proteins, enzymes and specialty chemical products that compete on performance, cost and sustainability. Redcliffe Labs | Series C | $42M | 🇮🇳 Omni-channel diagnostics platform combining digital and offline offerings to provide Indian consumers with quality testing at their doorstep ImmunOs Therapeutics AG | Series C | $11M | 🇨🇭 Immunotherapies that have a role in the innate immune system for cancer and autoimmune diseases
-
Last weeks fundraising rounds (09/08-09/14) in the biotech/pharma industry Chai Discovery | Seed | $30M Vironexis Biotherapeutics | Seed | $26M Bambusa Therapeutics | Seed | $15M CardiaTec Biosciences | Seed | $6.5M Safi Biotherapeutics Inc | Seed | $5M Candid Therapeutics | Series A | $370M Superluminal Medicines Inc.| Series A | $120M PANTERA | Sereis A | €93M Radiant Biotherapeutics | Series A | $35M Epsilogen Ltd | Series B| £12.5M PhoreMost Ltd | Series B | $12M NanoSyrinx | Series B | £10M ONL Therapeutics | Series D | $65M Inflammatix, Inc. | Series E | $57M F2G | Series H | $100M
-
VC Fundraising rounds north of $200M in 2024 (biotech) Xaira Therapeutics | $1B | Series A Formation Bio | $372M | Series D Arsenal Biosciences, Inc. | $325M | Series C Uniquity Bio | $300M | Series A Element Biosciences | $277M | Series D Cardurion Pharmaceuticals | $260M | Series B Alumis | $259M | Series C AltruBio Inc. | $225M | Series B
-
According to BioSpace's 2024 Life Sciences salary report, the average base salary in 2024 for the biopharma industry is $145,818. If you are moving for a job/hiring from other regions, it's a good practice to understand the compensation and cost of living in other regions vs. your own.
-
Good read from HRMorning about attracting Gen Z Talent (born between 1997-2012). This part really stood out to me: "Seventy-two percent of Gen Zers said working for a company whose mission and vision aligned with their own was “extremely” or “very” important. Similarly, 68% and 63.1% said the same about working for an employer committed to diversity, equity and inclusion and corporate social responsibility, respectively. Further, respondents suggested that these aspects were more crucial than working for a company that invests in the latest and greatest technologies or has a well-known brand." https://lnkd.in/dZ4dQRvS
-
Awesome opportunity at Connect Labs by Wexford!
Come join the Connect Labs by Wexford team in #Baltimore. We are looking for an experienced person to serve as the inaugural Director of Lab Operations in our new building in the University of Maryland BioPark. If you have a passion for science and supporting innovators, please apply (or help spread the word). Wexford Science & Technology, LLC, University of Maryland, Baltimore (UMB), Ventas, Inc., Greater Baltimore Committee, BioBuzz, UpSurge Baltimore #Innovation #Startups #Bioscience #Careers https://lnkd.in/gXTq3ewr
-
BioSpace's 2024 Life Sciences Salary report. Great resource as you plan for new hires in 2025 or are preparing for your next performance review. Link to the full report here: https://lnkd.in/ewSjsSU6
-
The BioHealth Capital Region (BHCR) is continuously ranked as one of the top biopharma clusters in US. #1 in Patents, #3 in lab space, and #2 in jobs according to Genetic Engineering & Biotechnology News. The Maryland Department of Commerce has over 1800 companies listed in their Life Sciences Directory for the state of Maryland. Below is an interesting breakdown of the different sectors that contribute to this vibrant ecosystem
-
-
Fractional roles offer a unique opportunity for companies to tap into seasoned expertise without the full-time commitment, allowing for greater flexibility and cost-effectiveness. For leaders, it’s a chance to bring their experience to multiple projects, fostering innovation across the industry. As the market continues to evolve, it will be interesting to see how these shifts influence the long-term dynamics of leadership and company growth in biopharma. https://lnkd.in/dUU-xCyp
Difficult Market Turns More Biopharma Leaders to Fractional Roles, Say Experts
biospace.com
-
The "life sciences industry" is a term that I heard early on in my career and was always confused by what people really meant. After 10 years of being in the industry, I've learned that there are a ton of sectors and sub-sectors of the life sciences industry. Below is a cheat sheet that I've created that highlights theses various sectors and sub-sectors. Drop a comment below if you'd like me send you the full PDF document. #lifesciences #careers #lifesciencejobs #biotechnology #pharma #medtech NexagenHR #venturecapital #digitalhealth #diagnostics #oncology #
